Peptide questions · Mazdutide

Mazdutide side effects: what studies and users report

Reviewed Evidence: EstablishedPublished by PepVault

The side effects most commonly reported for mazdutide are nausea, diarrhea and vomiting, among 8 the library lists; the library’s evidence on it includes controlled trials in people.

Its safety note opens: mazdutide's Chinese label carries a boxed warning for thyroid C-cell tumors seen in rodents (whether this applies to people is unknown), and it is not used with a personal or family history of medullary thyroid carcinoma or MEN 2.

What is commonly reported with mazdutide

  • Nausea
  • Diarrhea
  • Vomiting
  • Abdominal bloating
  • Abdominal pain
  • Injection site reaction
  • Dizziness
  • Acid reflux

Common here means the library lists it among the effects people most often report; the list doesn’t say how often each one happens.

Each effect, and the other metabolic & GLP-1 compounds the library lists it for
EffectAlso listed for (of 24)
Nausea21: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 17 more
Diarrhea20: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 16 more
Vomiting18: Semaglutide, Semaglutide (oral), Tirzepatide, Retatrutide and 14 more
Abdominal bloating1: Ecnoglutide
Abdominal pain7: Semaglutide (oral), Tirzepatide, Retatrutide, Dulaglutide and 3 more
Injection site reaction1: Eloralintide
Dizziness2: Exenatide, Pramlintide
Acid reflux1: VK2735
A smiling man in a grey t-shirt in his living room, holding his phone

Model. Individual results vary.

PepVault for iPhone

Track mazdutide in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Which mazdutide side effects the metabolic & GLP-1 group shares

Across the 25 metabolic & GLP-1 compounds in the library, the effects listed most often are nausea (22 of 25), diarrhea (21 of 25), vomiting (19 of 25) and constipation (14 of 25). Every effect on mazdutide’s list also appears for at least one other metabolic & GLP-1 compound, so nothing on it is mazdutide’s own.

What the mazdutide safety notes say

The library’s safety note

Mazdutide's Chinese label carries a boxed warning for thyroid C-cell tumors seen in rodents (whether this applies to people is unknown), and it is not used with a personal or family history of medullary thyroid carcinoma or MEN 2. In the GLORY-1 phase 3 trial, GI side effects affected 62.6% on 4 mg and 79.7% on 6 mg vs 20.0% on placebo, mostly mild and short-lived and concentrated in the step-ups; 1.0% stopped for side effects, the same as on placebo. Gallstones were reported in 2.0% vs 1.0%, one person had a mild gallstone-related pancreatitis, and resting heart rate was on average 2.6 beats per minute higher at week 48. The label carries the GLP-1 class cautions (pancreatitis, gallbladder disease, dehydration-related kidney injury, low blood sugar alongside insulin or sulfonylureas), asks people to report palpitations or a racing heart at rest, and advises stopping at least 3 months before a planned pregnancy because of its long half-life. These are label and trial findings to review with your clinician.

The library’s interaction note

Per its label, GLP-1 drugs like mazdutide slow stomach emptying and may change how oral medicines are absorbed, so drugs with a narrow margin (such as warfarin) are monitored more closely. With insulin or a sulfonylurea, the label suggests lowering their dose to limit low blood sugar. In its interaction studies, the shifts in atorvastatin, digoxin, metformin and warfarin levels were not expected to matter clinically. It is a GLP-1 drug itself, so it is not stacked with another one. Discuss all your medicines with your clinician.

These are reference notes from published research and reported use, not advice for a person: discuss your own situation with your clinician.

Where the mazdutide reports come from

The library rates the evidence on mazdutide as established: clinical trials or FDA-approved use exist.

Of the library’s 8 research notes on mazdutide, 6 rest on randomized trials, 1 on clinical data and 1 on community reports.

Our 4 study pages on mazdutide: 4 randomized trials.

So mazdutide has controlled trials in people to set its listed effects against.

What our mazdutide study pages report on safety

Mazdutide: 16.65% average weight loss at 60 weeks in GLORY-2

Randomized trial, human, 2026: Vomiting (53.1% vs 1.3%), nausea (46.9% vs 3.2%) and diarrhea (39.4% vs 6.5%) were the most common side effects, mostly mild to moderate. Side effects led 2.9% of the mazdutide group to stop treatment, versus 0% on placebo.

Mazdutide beat dulaglutide on HbA1c and weight at 28 weeks

Randomized trial, human, 2026: Diarrhea, nausea and vomiting were the most common side effects, and stomach and gut side effects were more frequent with mazdutide than with dulaglutide. In this head-to-head trial, mazdutide lowered blood sugar and weight more than dulaglutide 1.5 mg over 28 weeks, with more stomach and gut side effects.

Mazdutide: HbA1c fell 2.15% at 24 weeks in type 2 diabetes

Randomized trial, human, 2026: The most common side effects were diarrhea, decreased appetite and nausea. In this trial, mazdutide used alone lowered both HbA1c and body weight more than placebo over 24 weeks, and the common side effects were stomach-related.

Mazdutide: 14.01% weight loss at 48 weeks in GLORY-1 (6 mg arm)

Randomized trial, human, 2025: Stomach and gut side effects were the most common and were mostly mild to moderate, and 1.5% (4 mg), 0.5% (6 mg), and 1.0% (placebo) stopped treatment because of side effects. In a large placebo-controlled trial, both weekly mazdutide doses led to more weight loss than placebo over 48 weeks, with gut side effects the most common problem and few people stopping because of them.

Questions people ask

What are the side effects of mazdutide?

The side effects most commonly reported for mazdutide are nausea, diarrhea and vomiting, among 8 the library lists; the library’s evidence on it includes controlled trials in people.

Do mazdutide’s side effects come from human studies?

The library rates the evidence on mazdutide as established, and the library’s evidence on it includes controlled trials in people.

Which mazdutide side effects are its own?

None: each effect the library lists for mazdutide is listed for at least one other metabolic & GLP-1 compound too.

Does mazdutide interact with other medicines?

The library’s interaction note on mazdutide begins: Per its label, GLP-1 drugs like mazdutide slow stomach emptying and may change how oral medicines are absorbed, so drugs with a narrow margin (such as warfarin) are monitored more closely.

More on mazdutide

Track it in the app

PepVault for iPhone

Track mazdutide in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo